[
  {
    "ts": "2025-11-14T09:15:42+00:00",
    "headline": "Major Financing and Expanded SCRI Partnership Might Change the Case for Investing in Bristol-Myers Squibb (BMY)",
    "summary": "Bristol Myers Squibb completed a €5 billion senior unsecured note offering and announced an expanded collaboration with Sarah Cannon Research Institute to accelerate development and access to innovative cancer therapies by streamlining clinical trial delivery across more than 200 U.S. locations. This combination of large-scale financing and partnership expansion positions the company to enhance its oncology pipeline while improving financial flexibility for future initiatives. We'll explore...",
    "url": "https://finance.yahoo.com/news/major-financing-expanded-scri-partnership-091542864.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "9a38c51c-52f5-32f0-b61d-9da0dbf50d5c",
      "content": {
        "id": "9a38c51c-52f5-32f0-b61d-9da0dbf50d5c",
        "contentType": "STORY",
        "title": "Major Financing and Expanded SCRI Partnership Might Change the Case for Investing in Bristol-Myers Squibb (BMY)",
        "description": "",
        "summary": "Bristol Myers Squibb completed a €5 billion senior unsecured note offering and announced an expanded collaboration with Sarah Cannon Research Institute to accelerate development and access to innovative cancer therapies by streamlining clinical trial delivery across more than 200 U.S. locations. This combination of large-scale financing and partnership expansion positions the company to enhance its oncology pipeline while improving financial flexibility for future initiatives. We'll explore...",
        "pubDate": "2025-11-14T09:15:42Z",
        "displayTime": "2025-11-14T09:15:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/major-financing-expanded-scri-partnership-091542864.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/major-financing-expanded-scri-partnership-091542864.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T04:01:13+00:00",
    "headline": "3 Reasons to Avoid BMY and 1 Stock to Buy Instead",
    "summary": "While the S&P 500 is up 16.3% since May 2025, Bristol-Myers Squibb (currently trading at $48.73 per share) has lagged behind, posting a return of 10.4%. This might have investors contemplating their next move.",
    "url": "https://finance.yahoo.com/news/3-reasons-avoid-bmy-1-040113006.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "4182edc2-e68c-3552-ab2e-89fd8147a937",
      "content": {
        "id": "4182edc2-e68c-3552-ab2e-89fd8147a937",
        "contentType": "STORY",
        "title": "3 Reasons to Avoid BMY and 1 Stock to Buy Instead",
        "description": "",
        "summary": "While the S&P 500 is up 16.3% since May 2025, Bristol-Myers Squibb (currently trading at $48.73 per share) has lagged behind, posting a return of 10.4%. This might have investors contemplating their next move.",
        "pubDate": "2025-11-14T04:01:13Z",
        "displayTime": "2025-11-14T04:01:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "BMY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gk.7_kJOBQAPS7VxEfLOgw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YM1F85oh4xO4w1Qalh6PGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-avoid-bmy-1-040113006.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-avoid-bmy-1-040113006.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]